Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Mechanism of iroxanadine-induced cardioprotective effects

July 8, 2002

Neuroprotective effects of immunophilin ligands

July 8, 2002

SSR-181507: putative atypical antipsychotic with anxiolytic/antidepressant-like properties

July 8, 2002

Potential new applications of topiramate discussed at the CINP congress

July 8, 2002

New data on the efficacy and safety of the antidepressant S-20098

July 5, 2002

Antipsychotic effects demonstrated in patients for dopamine stabilizer OSU-6162

July 5, 2002

Preclinical profile of Lu-35-138 described at CINP congress

July 5, 2002

Biochemical profile of SM-13496, an atypical antipsychotic, characterized in vitro and in vivo

July 5, 2002

PK/PD analysis of schizophrenic patients treated with blonanserin

July 4, 2002

Neurochemical effects of new 5-HT6 antagonist in rat medial prefrontal cortex

July 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...